2012 UK Coagulation Testing Market Strategic Analysis: Supplier Shares and Sales Forecasts for 40 Tests

June 2012 | 409 pages | ID: F3B9A828F15EN
Venture Planning Group

Abstracts

Thisreport presents a comprehensive analysis of the UK coagulation market, including:

• Major issues pertaining to the UK coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
• Ten-year volume and sales forecasts for 40 coagulation procedures performed in UK hospitals and commercial laboratories, including typical coagulation daily work loads.
• Placement estimates for major automated and semiautomated systems.
• Review of current instrumentation technologies, and a feature comparison of nearly 50 leading analyzers.
• Ten-year reagent and instrument sales forecasts.
• Sales and market shares of leading reagent and instrument suppliers.
• Review of coagulation technologies and their potential market applications.
• Major opportunities for coagulation instruments and consumables.
• Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
• Business opportunities and strategic recommendations for instrument and reagent suppliers.

Contains 409 pages and 16 tables

Contents

WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Major Routine and Special Coagulation Tests
  1. Introduction
  2. Activated Partial Thromboplastin Time (APTT)
  3. Alpha-2 Antiplasmin
  4. Antithrombin III
  5. Bleeding Time
  6. D-Dimer
  7. Ethanol Flocculation Test
  8. Euglobulin Lysis
  9. Factor Assays
    a. Introduction
    b. Factor II
    c. Factor V/Factor V Leiden
    d. Factor VII
    e. Factor VIII
    f. Factor IX
    g. Factor IXa
    h. Factor X (Stuart Factor)
    i. Factor Xa
    j. Factor XI
    k. Factor XII
    l. Factor XIII
  10. Fibrin Degradation Products
  11. Fibrinogen
  12. Heparin
  13. Hirudin
  14. Hypercoagulability and Thrombosis
  15. Lipoprotein a
  16. Plasmin
  17. Plasminogen
  18. Plasminogen Activator Inhibitor (PAI)
  19. Platelet Function Tests
  20. Platelet Aggregation
  21. Proteins C and S
  22. Prothrombin Fragment 1.2
  23. Prothrombin Time (PT)
  24. Reptilase Time
  25. Thrombin Time
  26. Tissue-Type Plasminogen Activator (t-PA)
  27. Von Willebrand's Factor
B. Instrumentation Review
      Introduction
      Benk Hemolab
      Benk TRT Thrombotimer
      Bio/Data MCA 310
      Bio/Data MCA 210
      Bio/Data PAP-4C D/4D/4C
      Cardiovascular Diagnostics COAG
      Diagnostica Stago STA Compact
      Diagnostica Stago STA-R
      Diagnostica Stago Star 4/8
      Helena Laboratories Cascade 480
      Helena Laboratories Cascade M
      Helena Laboratories PACKS-4
      Helena THOR
      Instrumentation Laboratory ACL 100 and 1000 series
      Instrumentation Laboratory ACL6000
      Instrumentation Laboratory ACL7000
      Instrumentation Laboratory ACL9000
      Instrumentation Laboratory Electra 1000C
      Instrumentation Laboratory Electra 1400C
      Instrumentation Laboratory Electra 1600/C
      Instrumentation Laboratory Electra 1800C
      Instrumentation Laboratory Futura
      ITC Hemochron 8000
      Roche Diagnostics CoaguChek
      Siemens BCS
      Siemens BCT
      Siemens BF II/Fibrintimer Series
      Sysmex CA-50
      Sysmex CA-500
      Sysmex CA-1500
      Sysmex CA-5000/CA-1000
      Sysmex CA-6000
      Sysmex CA-7000
      Teco Coatron II/Jr./AccuStasis 5000
      Trinity Biotech Amax CS190
      Trinity Biotech Amax CS400
      Trinity Biotech Coag-A-Mate Max
      Trinity Biotech KC 40, 4A, 1A Series
      Trinity Biotech MDA 180
      Trinity Biotech Coag-A-Mate MTX
      Trinity Biotech Coag-A-Mate RA4
      Trinity Biotech Coag-A-Mate XC/Plus
      Trinity Biotech Coag-A-Mate XM
C. Major in Vitro Diagnostic Technologies and Their Potential Applications
  1. Chromogenic Substrates
  2. Monoclonal and Polyclonal Antibodies
  3. Immunoassays
    a. Applications
    b. Technological Principle
    c. Enzyme Immunoassays (EIA)
      Overview
      ELISA
      EMIT
      Dot Immunobinding Assays
      Capillary Immunoassays
      Enzyme Amplification
      Electrochemical Immunoassay
    d. Fluorescent Immunoassays
      Fluorescence Polarization
      Time-Resolved Pulse Fluorescence
      Fluorescence Lifetime
    e. Latex Agglutination
    f. Immunoprecipitation
  4. Microcomputers
  5. Automation
  6. Robotics
  7. DNA Probes
    a. Overview
    b. Amplification Methods
      PCR
      Ligase Chain Reaction
      Branched DNA
      Q-Beta Replicase
      NASBA
      SDA
      3 SR
      HPA
      Two-Tiered System
      LAT
  8. Artificial Intelligence
  9. Dry Chemistry
  10. Biosensors
D. Worldwide Market Overview
  1. Business Environment
  2. Market Structure
  3. Market Size and Growth
  4. POC Testing Market

UK

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers

MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types Of Distributors
  7. Market Segmentation

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPETITIVE ASSESSMENTS

      Abbott
      American Diagnostica
      Avocet Medical
      Axis-Shield
      Beckman Coulter
      Becton Dickinson
      Bio/Data Corporation
      Biosite
      Chrono-Log
      Corgenix Medical
      Diagnostica Stago
      Helena Laboratories
      HYPEN BioMed
      Instrumentation Laboratory
      ITC
      Nanogen
      Roche
      Siemens
      Sienco
      Sysmex
      Thermo Fischer
      Trinity Biotech
      ZyCare

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing Activated Clotting Time Tests
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D-dimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrand's Factor Tests
Worldwide, All Market Segments, Laboratories Performing Coagulation Tests By Country, 2010
Worldwide, All Market Segments, Total Coagulation Test Volume By Country, 2010-2020
Worldwide, All Market Segments, Total Coagulation Reagent Market By Country, 2010-2020
Worldwide, All Market Segments, Total Coagulation Instrument Market By Country, 2010-2020
Worldwide, All Market Segments, Total Coagulation Diagnostics Market By Country, 2010-2020
Executive Summary Table: U.K., Total Coagulation Diagnostics Market By Market Segment and Product Category, 2010-2020
U.K., Laboratories Performing Coagulation Tests By Market Segment, 2010
U.K., Hospital Laboratories Performing Coagulation Tests By Bed Size, 2010
U.K., Commercial/Private Laboratories Performing Coagulation Tests By Annual Test Volume, 2010
U.K., Hospital Laboratories Average Daily Test Volume, 2010
U.K., Commercial/Private Laboratories Average Daily Test Volume, 2010
U.K., Total Coagulation Test Volume By Market Segment, 2010-2020
U.K., All Market Segments Coagulation Test Volume, 2010-2020
U.K., Hospital Laboratories Coagulation Test Volume, 2010-2020
U.K., Commercial/Private Laboratories Coagulation Test Volume, 2010-2020
U.K., Coagulation Reagent Market By Market Segment, 2010-2020
U.K., Major Suppliers of Coagulation Reagents Estimated Sales and Market Shares, 2010
U.K., Coagulation Instrument Market By Market Segment, 2010
U.K., Major Suppliers of Coagulation Analyzers, Estimated Total Instrument Placements and Market Shares, 2010
U.K., Major Suppliers of Coagulation Analyzers, Estimated Placements and Installed Base By Supplier and Model, 2010
U.K., Major Suppliers of Coagulation Analyzers, Estimated Instrument Sales and Market Shares, 2010
U.K., Total Coagulation Diagnostics Market By Product Category, 2010-2020
U.K., Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares, 2010